CYP1A1 and metabolic dysfunction-associated steatotic liver disease: Recent results obtained using CYP1A1(-/-) mice demonstrate that elevated expression of CYP1A1 protects against the development of non-alcoholic fatty liver disease [27], and dysregulation of the CYP1A1 gene is reported to be involved in the transport and metabolism of lipids [28].